メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
並べ替え順
Keyphrases
Lamivudine
100%
Allogeneic Hematopoietic Stem Cell Transplant Recipients
100%
HBV Infection
100%
Cell Transplantation
50%
Allogeneic
33%
Hepatitis B Virus
33%
Hepatitis B Virus Reactivation
33%
Chronic Hepatitis B Virus Infection
33%
Major Complications
16%
High Risk
16%
Steroid Therapy
16%
Immunosuppressive Therapy
16%
Patient Management
16%
DNA Polymerase Activity
16%
Virus Diseases
16%
Prolonged Administration
16%
Fatal Hepatitis
16%
Virus Load
16%
Chronic Graft-versus-host Disease (cGVHD)
16%
Solid Organ Transplantation
16%
Clinical Situations
16%
Hepatitis B Virus Carrier
16%
Medicine and Dentistry
Hematopoietic Stem Cell Transplantation
100%
Hepatitis B
100%
Lamivudine
100%
Hepatitis B Virus
83%
Cell Transplantation
50%
Chronic Hepatitis B
33%
Virus Infection
16%
Immunosuppressive Treatment
16%
Steroid Therapy
16%
Acute Graft Versus Host Disease
16%
Solid Organ Transplantation
16%
Virus Reactivation
16%
Virus Carrier
16%
DNA Polymerase
16%
Immunology and Microbiology
Hepatitis B
100%
Hematopoietic Stem Cell Transplantation
100%
Hepatitis B Virus
100%
Cell Transplantation
60%
Solid Organ Transplantation
20%
Viral Load
20%
Acute Graft Versus Host Disease
20%
DNA Polymerase
20%
Virus Reactivation
20%
Virus Carrier
20%
Immunosuppressive Therapy
20%
Steroid
20%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis B
100%
Lamivudine
100%
Hepatitis B Virus
83%
Chronic Hepatitis B
33%
Virus Infection
16%
Immunosuppressive Agent
16%
DNA Polymerase
16%
Acute Graft Versus Host Disease
16%
Virus Carrier
16%
Steroids
16%
Nursing and Health Professions
Lamivudine
100%
deoxyribonucleic acid nucleotidyl transferase
16%